Pages

• Home
• 2024 ESG at a Glance
• AAPS After Hours Networking Event
• AAPS After Hours Networking Event – Thank You
• Campaign
  • Consult + Coach
  • EvolvePK+
  • First-in-Human
  • Pulmonary Package
  • Safety first with Liver Safety+
• Career Center
• Case-studies
  • Boosting NAFLD Study Enrollment: Leveraging Simulation Tools to Overcome Study Recruitment Hurdles
  • Confirming Model Optimization: OBESITYsym Predicts the Efficacy and Tolerability of Top Three Weight Loss Drugs
  • Predicting Effective Drug Formulations Before Phase 1 Clinical Trials: How Roche Used GastroPlus® to Investigate the Impact of Solubility & Permeability on Bioavailability
  • Evaluating Hepatoxicity Before Late-Stage Trials: How Biohaven Used QST to Ensure Liver Safety and Gain Regulatory Approval
  • Identifying the Right Drug Dosage to Prevent DILI: How Astellas Used QST to Progress Fezolinetant to Phase 3 and Beyond
  • Strengthening Protocol Compliance: How Simulation-Driven Training Increased Investigator Engagement and Understanding
• Client Page
• Clients
  • GastroPlus® Welcome
• Conference News and Events
• Cookie Notice
• COVID-19 and Simulations Plus
• DILIsym® Services
  • RENAsym Scientific Advisory Board
  • QSP Team
  • RENAsym
• GastroPlus Utilization and Impact Survey-Services
• GastroPlus Utilization and Impact Survey-Software
• GastroPlus X
• GPUG
• GPX™ News and Events
• Incubator and Biotech Startup Package
• Internship+
• Learning Services
• Lixoft
• Marketo3 Test Form
• News and Events
• Noncompartmental PK/TK Analysis
• Physiologically Based Pharmacokinetic (PBPK) Software
• PKPlus™ Academic Licensing
• Press Release Sign Up Form
• QSAR/PBPK
• Regulatory Strategies Center of Excellence
• Resident Clinical Pharmacology Services
• Software Products
• Subscribe to GPUG Weekly Digest
• Systemic Lupus Erythematosus
• University License Request Form
• Workshop Wait List
• Software
  • Software Overview
• Contact
  • Contact Us for ClinPharm Services
• Services
  • Adaptive Learning & Insights (ALI) Services
  • Clinical Pharmacology & Pharmacometrics (CPP) Consulting
  • Continuing Medical Education
  • Experiential Simulation
  • Medical Communications Services
  • Physiologically Based Pharmacokinetic (PBPK) Consulting
  • Protocol Optimization
  • Overview
  • Early Drug Discovery
  • Global Regulatory Strategies
  • Pharmaceutical
    • PBPK Modeling and Simulation
    • Regulatory and Scientific Writing
    • Pharmacometric Data Assembly
    • Quantitative Systems Pharmacology (QSP) Modeling
    • Training and Workshops
    • Model-Driven Development Strategies
    • PopPK & Exposure Response Modeling
    • Liver Safety Modeling and Analysis
      • DILIsym Discovery Support Program (DDSP)
    • PK/PD Support
    • QSP Modeling of MASLD & MASH
  • Chemical, Cosmetics, and Food Industries
    • PBTK Modeling and Simulation
• Industries
  • Overview
  • Deep Machine Learning & Technology
  • Chemicals
  • Food/Cosmetic
• Resource Center
  • Resource Thank You
  • Blog
  • FAQs
  • Journal Articles
  • Posters
  • Product Brochures
  • Videos
  • Webinars
  • White Papers
• Webinars
• Workshops
• Investors
  • 2022 ESG at a Glance
  • 2023 ESG at a Glance
  • Conference Calls
  • Corporate Development Initiative
  • ESG
  • Board of Directors
  • Press Releases
  • SEC Filings
  • Shareholder Information
• Pharma + Biotech
  • Early Discovery
  • Preclinical Development
  • Clinical Development
  • Post-Patent
• About
  • Simulations Plus Scientific Advisory Board
  • Simulations Plus Team
  • Careers
  • Leadership
  • Partners and Collaborators
• Academic & Reference Site License Application
• Discuss My Project Needs
• Good Clinical Practice Training Registration
  • GCP Thank You
• Privacy Notice
• Schedule A Software Demo
• Software Evaluation Request Form
• Terms of Use
• DILIsym Development
• DILIsym Scientific Advisory Board
• Software Installation
• Contact Support
• The Simulations Plus Customer Portal